Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss needs more research for better treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Minoxidil promotes hair growth in male pattern baldness.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Smoking linked to hair loss in Asian men.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Certain hairstyles and less hair oil use in African American girls can lead to scalp conditions like traction alopecia and seborrheic dermatitis.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.